A novel osmotic pump tablet using core of drug-resin complexes for time-controlled delivery system

Yakugaku Zasshi

Volumn 128, Issue 5, 2008, Pages 773-782

  Wang, Chao ^a   Chen, Fei ^a   Li, Ji Zhong ^a   Tang, Hai ^a   Li, Xiang ^a   Yan, Ke Shu ^a   Ye, Guan Hao ^a   Pan, Wei San ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Chronotherapy; Drug resin complexes; Osmotic pump tablet; Propranolol hydrochloride; Spherical symmetric design; Time controlled delivery

Indexed keywords

CELLULOSE ACETATE; MACROGOL; PROPRANOLOL; RESIN; SODIUM CHLORIDE;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; IONIC STRENGTH; OSMOTIC PUMP; PH; TABLET;

CELLULOSE; CHEMISTRY, PHARMACEUTICAL; CHRONOTHERAPY; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; DRUG DESIGN; OSMOSIS; POLYETHYLENE GLYCOLS; PROPRANOLOL; SODIUM CHLORIDE; SOLUBILITY; TABLETS; TECHNOLOGY, PHARMACEUTICAL;

EID: 43449092902     PISSN: 00316903     EISSN: 13475231     Source Type: Journal    
DOI: 10.1248/yakushi.128.773     Document Type: Article

References (32)

1. Rose S., Nelson J. F., Aus. J. Exp. Biol., 33, 415-420 (1995).
2. Higuchi T., Leeper H. M., Improved osmotic dispenser employing magnesium sulfate and magnesium chloride. US Patent No. 3760804, (1973).
3. Higuchi T., Osmotic dispenser with collapsible supply container. US Patent No. 3760805, (1973).
4. Theeuwes F., J. Pharm. Sci., 64, 1987-1991 (1975).
5. Cortese R., Theeuwes F., Osmotic device with hydrogel driving member. US Patent No. 4327725, (1982).
6. Thombre A. G., Appel L. E., J. Controlled Release, 94, 75-89 (2004).
7. Li X., Pan W., J. Controlled Release, 96, 359-367 (2004).
8. Okimoto K., Tokunaga Y., Int. J. Pharm., 286, 81-88 (2004).
9. Raghunathan Y., Prolonged release pharmaceutical preparations. U. S. Patent No. 4221778, (1980).
10. Raghunathan Y., Controlled release pharmaceutical preparations. U. S. Patent No. 4847077, (1989).
11. Sriwongjanya M., Bodmeier R., Eur. J. Pharm. Biopharm., 46, 321-327 (1998).
12. Schlichting D. A., Ionic polymers as drug carriers., Controlled Drug Delivery. Vol. 1, In Bruck, S. D. (Ed.) CRC Press, Boca Raton, FL, 1983 pp. 149-173.
13. Motycka S., Newth C. J. L., Nairn J. G., J. Pharm. Sci., 74, 643-646 (1985).
14. Ragunathan Y., Amsel L., Hinsvark O., Bryant W., J. Pharm. Sci., 70, 379-384 (1981).
15. Prapaitrakul W., Whitworth C. W., J. Microencapsul., 6, 213-218 (1989).
16. Moldenhauer M. G., Nairn J. G., J. Pharm. Sci., 79, 659-666 (1990).
17. Taylan B., Capan Y., J. Controlled Release, 3, 11-20 (1996).
18. Halder A., Maiti S., Sa B., In. J. Pharm., 302, 84-94 (2005).
19. Åkerman S., Svarfvar B., Kontturi K., Näsman J., Urtti A., Paronen P., Järvinen K., Int. J. Pharm., 178, 67-75 (1999).
20. Sriwongjanya M., Bodmeier R., Int. J. Pharm., 158, 29-38 (1997).
21. Gaylen M., Gregory A., McClelland S., Sutton C., J. Controlled Release, 16, 237-243 (1991).
22. Sriwongjanya M., Bodmeier R., Eur. J. Pharm. Biopharm., 46, 321-327 (1998).
23. Gazzaniga A., Iamartino P., Maffione G., Sangalli M. E., Int. J. Pharm., 108, 73-83 (1994).
24. Matsuo M., Nakamura C., Arimori K., Nakamura C., Nakano M., Chem. Pharm. Bull., 43, 311-314 (1995).
25. U. S. Pharmacopoeia, National Formulary, 2002 pp. 2340-2344.
26. Pen K. K., Wong C. F., Drug. Dev. Ind. Pharm., 26, 723-730 (2000).
27. Moore J. W., Flanner H. H., Pharm. Tech., 20, 64-74 (1996).
28. Shah V. P., Tsong Y., Sathe P., Pharm. Res., 15, 889-896 (1998).
29. Theeuwes F., J. Pharm. Sci., 64, 1987 (1975).
30. Takayama K., Imaizumi H., Nambu N., Nagai T., Chem. Pharm. Bull., 33, 292 (1985).
31. Douglas C., Montgomery Design and Analysis of Experiments John, Wiley and Sons, New York, 1976.
32. Takayama K., Nagai T., Chem. Pharm. Bull., 37, 160 (1989).